Status:
TERMINATED
Evoked Retinal Response
Lead Sponsor:
Columbia University
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in ...
Detailed Description
Patients affected by retinitis pigmentosa (RP) and related diseases suffer loss of vision due to death of photoreceptor cells. The investigators have observed that short pulses of focused ultrasound c...
Eligibility Criteria
Inclusion
- retinitis pigmentosa
- legally blind in at least one eye
Exclusion
- unable to lay down on an exam table
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01415453
Start Date
July 1 2011
End Date
June 1 2012
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032